Nozomu Sato Selected Research

Nozomu Sato Research Topics

11	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2023 - 11/2009
5	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2019 - 04/2010
2	Huntington Disease (Huntington's Disease) 10/2023 - 12/2012
2	Cerebellar Ataxia (Dysmetria) 11/2017 - 11/2011
1	Spastic Paraparesis 07/2021
1	Oculodentodigital Dysplasia 07/2021
1	Autistic Disorder (Autism) 10/2020
1	Proteostasis Deficiencies 04/2017
1	Motor Neuron Disease (Primary Lateral Sclerosis) 04/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2017
1	Neuromyelitis Optica (Devic's Disease) 01/2017
1	Pheochromocytoma 01/2013
1	Human Influenza (Influenza) 01/2011
1	Machado-Joseph Disease (Spinocerebellar Ataxia Type 3) 11/2009

4	NucleotidesIBA 11/2017 - 11/2009
4	polyglutamineIBA 01/2013 - 11/2009
3	Calcium Channels (Calcium Channel)IBA 10/2019 - 04/2010
2	RNA (Ribonucleic Acid)IBA 04/2017 - 12/2013
2	PENTAIBA 12/2013 - 11/2009
2	voltage-dependent calcium channel (P-Q type)IBA 12/2012 - 04/2010
1	Replication Protein AIBA 10/2023
1	Baclofen FDA LinkGeneric 07/2021
1	disodium salt olean-11,13(18)-diene-3,30-diol dihemiphthalateIBA 07/2021
1	DNA (Deoxyribonucleic Acid)IBA 10/2020
1	Proteins (Proteins, Gene)FDA Link 04/2017
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 04/2017
1	Methotrexate (Mexate)FDA LinkGeneric 01/2017
1	Nuclear Export Signals (Nuclear Export Signal)IBA 01/2013
1	Messenger RNA (mRNA)IBA 12/2012
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 12/2012
1	Inositol (Myoinositol)IBA 03/2012
1	thymidine kinase 2IBA 11/2011
1	Amantadine (Aman)FDA LinkGeneric 01/2011

1	Therapeutics 07/2021